Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Zevra Therapeutics (ZVRA) Return on Assets (2016 - 2025)

Historic Return on Assets for Zevra Therapeutics (ZVRA) over the last 10 years, with Q3 2025 value amounting to 0.13%.

  • Zevra Therapeutics' Return on Assets rose 6700.0% to 0.13% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.13%, marking a year-over-year increase of 6700.0%. This contributed to the annual value of 0.6% for FY2024, which is 2800.0% down from last year.
  • As of Q3 2025, Zevra Therapeutics' Return on Assets stood at 0.13%, which was up 6700.0% from 0.01% recorded in Q2 2025.
  • In the past 5 years, Zevra Therapeutics' Return on Assets registered a high of 0.13% during Q3 2025, and its lowest value of 0.57% during Q4 2024.
  • For the 5-year period, Zevra Therapeutics' Return on Assets averaged around 0.23%, with its median value being 0.2% (2023).
  • Per our database at Business Quant, Zevra Therapeutics' Return on Assets skyrocketed by 15100bps in 2021 and then plummeted by -5000bps in 2023.
  • Over the past 5 years, Zevra Therapeutics' Return on Assets (Quarter) stood at 0.06% in 2021, then plummeted by -145bps to 0.16% in 2022, then tumbled by -91bps to 0.3% in 2023, then tumbled by -93bps to 0.57% in 2024, then skyrocketed by 124bps to 0.13% in 2025.
  • Its Return on Assets was 0.13% in Q3 2025, compared to 0.01% in Q2 2025 and 0.52% in Q1 2025.